To extend the significance of the present research, we performed a meta-analysis across 8 kinds of metabolic diseases including Ankylosing spondylitis, liver cirrhosis, Colorectal Cancer, Parkinson disease (2 cohorts including a European cohort (PDA) and a Chinese cohort (PDB)), Rheumatoid Arthritis and T2D. (PRJNA433459, PRJEB24529, ERP008729, SRP011011, SRP008047, ERP006678, ERP019674, SRP100575, ERP005860 and ERP003612) 
